Science
Mechanism of Action
Functions as a competitive tyrosinase inhibitor, blocking the rate-limiting enzyme in melanin production without damaging melanocyte cells. Simultaneously scavenges free radicals and reduces inflammatory pathways by inhibiting fibroblast growth factors and 15-lipoxygenase activity.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 0.5% concentration demonstrated significant tyrosinase inhibition and melanin synthesis reduction in controlled laboratory studies
- 02 1.0% formulation produced visible hyperpigmentation reduction and improved skin tone uniformity over 12 weeks in clinical evaluation
Transparency
Dusting Analysis
Effective concentrations start at 0.5% with optimal results at 1.0%. Any formulation below 0.1% would provide negligible tyrosinase inhibition and brightening benefits.
The Formula
Formulation
Stability
Prone to oxidation and browning like other phenolic compounds. Requires antioxidants such as sodium metabisulfite and chelating agents for stability in aqueous systems.
Synergies
- Sodium Metabisulfite
- Chelating agents
- Other antioxidants
Conflicts
- Strong oxidizing agents
- Ferric salts
- Strong alkaline compounds
Safety
Safety Profile
Considered safer than hydroquinone due to non-cytotoxic action. Oral LD50 in rats is 3000 mg/kg. Widely used up to 1.0% concentration without formal CIR review.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A well-researched, gentler alternative to hydroquinone with proven brightening efficacy and excellent safety profile across all skin types.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources